Clearmind Medicine (CMND) EBITDA (2022 - 2026)
Clearmind Medicine (CMND) posted quarterly EBITDA of -$1.5 million for Q2 2026, down 101.96% year-over-year from $78.7 million in Q2 2025, and up 59.49% quarter-over-quarter from -$3.8 million in Q1 2026.
Clearmind Medicine (CMND) EBITDA (2022 - 2026) Analysis & Trends
Clearmind Medicine's EBITDA history runs 5 years deep, the most recent figure standing at -$1.5 million for Q2 2026.
- In Q2 2026, EBITDA fell 101.96% year-over-year to -$1.5 million; the TTM figure through Apr 2026 stood at -$7.2 million (down 43.7% YoY), while the FY2025 annual figure was -$3.6 million, up 30.51% from the prior year.
- EBITDA for Q2 2026 stood at -$1.5 million, up from -$3.8 million in the prior quarter.
- The five-year high for EBITDA was $11.1 billion in Q3 2022, with the low at -$11.1 billion in Q4 2022.
- The 5-year median for EBITDA is -$1.3 million (2025), against an average of -$1.6 million.
- The sharpest annual moves came in 2023 and 2026: EBITDA soared 99.96% in 2023, then tumbled 268.59% in 2026.
- Clearmind Medicine's EBITDA stood at -$11.1 billion in 2022, then jumped by 99.96% to -$4.1 million in 2023, then soared by 71.44% to -$1.2 million in 2024, then soared by 52.75% to -$550101.0 in 2025, then sank by 179.83% to -$1.5 million in 2026.
- Business Quant data shows CMND's EBITDA at -$1.5 million in Q2 2026, -$3.8 million in Q1 2026, and -$550101.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 1.29 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 493.00 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -815.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 325.05 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 231.44 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -1.55 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 133.12 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -375.75 Mn |
| 10 | Clearmind Medicine | 520,887.91 | -13.07 Mn | - | -2.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -1.54 Mn |
| Jan 31, 2026 | -3.80 Mn |
| Oct 31, 2025 | -550,101.00 |
| Jul 31, 2025 | -1.30 Mn |
| Apr 30, 2025 | -762,216.00 |
| Jan 31, 2025 | -1.03 Mn |
| Oct 31, 2024 | -1.16 Mn |
| Jul 31, 2024 | -2.05 Mn |
| Apr 30, 2024 | -869,833.00 |
| Jan 31, 2024 | -1.17 Mn |
| Oct 31, 2023 | -4.08 Mn |
| Jul 31, 2023 | -581,593.00 |
| Apr 30, 2023 | -1.22 Mn |
| Jan 31, 2023 | -1.83 Mn |
| Oct 31, 2022 | -11.14 Bn |
| Jul 31, 2022 | 11.14 Bn |
| Apr 30, 2022 | -1.75 Mn |
| Jan 31, 2022 | -1.65 Mn |